Peptilogics
PrivateLast Round
Series B
Extension
Oct 16, 2025
Est. Valuation
$420M
Total Funding Raised
$135.67M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Peptilogics is a biotechnology company that develops novel peptide therapeutics using an AI-powered drug discovery platform to treat multidrug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peptilogics Comparables
Compare Peptilogics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Osteal Therapeutics | 83% | |
| Trellis Bioscience | 82% | |
| Omnix Medical Ltd. | 78% | |
Peptilogics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Oct 16, 2025 | ||||
| Grant | Jan 9, 2025 | ||||
| Series B | Dec 21, 2020 | ||||
| Grant | Feb 25, 2020 | ||||
| Series A | Sep 29, 2017 | ||||
Seed | Oct 21, 2016 |
Key People
Founding team and executive leadership
Peptilogics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pittsburgh Life Sciences Greenhouse | Seed |
| Narya Capital | Series B Extension |
| AMR Action Fund | Series B Extension |
| BlueTree Allied Angels | Series A |
| CARB-X | Grant |
| Beyond Ventures | Series B Extension |
| Founders Fund | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 16, 2025
$78M round led by Founders Fund and Presight Capital.
- Jan 9, 2025
Secured $3.3M in grant funding.
Peptilogics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Peptilogics's valuation, stock price, and market status.